Comparing left vs right liver lobes for transplants with borderline ratios
Part of Digestive system clinical trials.
This study compares using the left or right part of a donated liver for adult recipients who have a lower-than-ideal graft-to-recipient weight ratio (GRWR). It aims to find which side works better when the donor liver is relatively small.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a living donor liver transplant.
- Your estimated donor liver size (GRWR) is less than 1.
- You do not have kidney problems, a blood clot in your portal vein, or other major blood vessel issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special way of moving blood through the donor abdomen before surgery can improve liver (and other organ) transplant quality. It may help because doctors can check how well the liver seems to be working before it’s actually used.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
This study compares how different surgical techniques for removing and preparing donor livers affect patient outcomes after transplantation. You would be tracked to see how well your transplanted liver works depending on the method used to obtain it.
This study looks at how genetic differences between liver donors and recipients affect fat buildup in the new liver after transplantation. It may help doctors understand why some transplanted livers develop steatosis (fatty liver) after the surgery.
This trial tests whether a medication (octreotide) or a minor surgical procedure (tying off a spleen artery) works better to help a smaller-than-ideal liver graft work well after a living donor transplant. The goal is to improve blood flow and prevent complications.
Hear when a new Liver Transplant; Complications trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.